Physician
Brattleboro Memorial Hospital
Brattleboro Memorial Hospital was paid $2.37M by Medicaid between Jan 2018 and Dec 2024, across 90 billing codes. Its largest line is 99284, emergency room visit (serious) — 21% of everything it billed.
33Billing provider infoBRATTLEBORO MEMORIAL HOSPITAL
BRATTLEBORO, VT 05301
BRATTLEBORO, VT 05301
33aNPI1306849708assigned 05/31/2005
33bProvider typeFamily Medicine Physician
28Total paid$2.37M
24GClaims117,153
24DCodes billed90
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Vermont
Rank by total paid#8 of 53
Median peer was paid$77K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,243 | $435K | |
| 2019 | 28,829 | $490K | |
| 2020 | 14,870 | $260K | |
| 2021 | 13,684 | $312K | |
| 2022 | 12,672 | $342K | |
| 2023 | 12,970 | $310K | |
| 2024incomplete | 8,885 | $218K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 9,210 | 7,348 | $498K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 21,099 | 16,785 | $490K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 21,288 | 17,066 | $408K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 8,536 | 7,015 | $350K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.5% | 623 | 476 | $84K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.0% | 4,493 | 2,738 | $47K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.7% | 1,182 | 1,082 | $40K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.6% | 3,243 | 2,310 | $38K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.5% | 15,616 | 10,978 | $36K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 1.3% | 1,338 | 643 | $30K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 644 | 534 | $26K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.1% | 646 | 559 | $25K |
78 more codes
| 99308 | Subsequent nursing facility care, per day, straightforward | 1.0% | 2,843 | $25K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 994 | $24K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,181 | $20K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 859 | $19K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 337 | $17K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 470 | $15K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,360 | $14K |
| 80053 | Comprehensive metabolic panel | <1% | 1,773 | $14K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 497 | $13K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 251 | $13K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 600 | $11K |
| 90461 | <1% | 1,074 | $10K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 17 | $9K |
| 99205 | Prolong outpt/office vis | <1% | 211 | $9K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,820 | $9K |
| 64615 | <1% | 92 | $7K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 201 | $6K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 404 | $5K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 70 | $5K |
| 80305 | <1% | 1,397 | $4K | |
| 81000 | <1% | 687 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 666 | $3K |
| 99354 | <1% | 89 | $3K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 45 | $3K |
| 99307 | <1% | 323 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 365 | $3K |
| 90480 | <1% | 86 | $3K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 137 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 57 | $2K |
| 99443 | <1% | 124 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 152 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 64 | $1K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 643 | $1K |
| 99442 | <1% | 69 | $1K | |
| 59025 | Fetal non-stress test | <1% | 129 | $1K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 323 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 259 | $973.46 |
| 90686 | <1% | 1,732 | $891.28 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 27 | $808.35 |
| 81003 | <1% | 924 | $752.55 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,037 | $560.96 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 12 | $557.69 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 16 | $512.93 |
| 99223 | Prolong inpt eval add15 m | <1% | 12 | $473.37 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 32 | $452.20 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 20 | $423.61 |
| 99173 | <1% | 720 | $347.65 | |
| 99335 | <1% | 19 | $316.11 | |
| 20610 | <1% | 30 | $306.39 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 91 | $276.85 |
| 84703 | <1% | 70 | $255.49 | |
| 11721 | <1% | 29 | $232.31 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 53 | $192.35 |
| 87430 | <1% | 201 | $188.72 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 32 | $177.39 |
| 99217 | <1% | 18 | $160.94 | |
| 99310 | Prolong nursin fac eval 15m | <1% | 18 | $137.00 |
| 87400 | <1% | 30 | $132.79 | |
| 91320 | <1% | 17 | $131.15 | |
| 94760 | <1% | 146 | $125.99 | |
| 80061 | Lipid panel | <1% | 12 | $110.16 |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 84 | $105.00 |
| 93000 | <1% | 16 | $82.02 | |
| G9001 | Coordinated care fee, initial rate | <1% | 13 | $81.60 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 25 | $79.26 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 27 | $79.20 |
| 99441 | <1% | 24 | $70.70 | |
| 87081 | <1% | 12 | $51.48 | |
| 99000 | <1% | 532 | $41.63 | |
| 83690 | <1% | 16 | $35.52 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 129 | $26.22 |
| 90723 | 0% | 31 | $0.00 | |
| 90633 | 0% | 12 | $0.00 | |
| 90648 | 0% | 51 | $0.00 | |
| 90661 | 0% | 37 | $0.00 | |
| 90685 | 0% | 93 | $0.00 | |
| 90670 | 0% | 81 | $0.00 | |
| 99080 | 0% | 85 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAMPNEY, REINA (CREDENTIALING MANAGER)